BioPharma Solutions
Scalable Expert Pathology Solutions for Translational Science, Biomarker Assessments, Clinical Trial Support, and AI
Delivering multi-reader, high-throughput pathology services with the rigor and consistency required by growing BioPharma needs.
The reality
Diagnostic and biological complexity create demand for pathology expertise
Biomarker-driven programs, multimodal data, and growing number of clinical studies place sustained pressure on translational teams and pathologists.
01
Growing number of clinical programs with multiple trials and increase in biomarker testing creates demands for pathology expertise
02
Limited access to pathologists, especially those with specialization expertise
03
Utilization of limited biopharma headcounts on time and labor intensive preparation and review tasks
04
Pressure to maintain rigor while accelerating timelines
What we provide
Expert pathology interpretation across the drug program lifecycle
Scribe integrates licensed and board-certified pathology interpretation into BioPharma workflows to handle growing demand while preserving quality and scientific integrity.
Core Pathology Interpretation
High-volume expert pathology review for biomarker programs, translational research, and clinical studies.
H&E, IHC, and multiplex scoring across tissue types
Region marking and segmentation for downstream analysis
Quality & Study Readiness
Rigorous quality control and multi-reader validation to support regulatory and scientific requirements.
Tissue QC for sequencing and spatial biology workflows
Multi-reader consensus panels for statistical robustness
Protocol-aligned scoring and adjudication for study consistency
AI Programs
Physician-validated datasets and embedded support for AI development and validation initiatives.
AI training dataset creation with physician-validated ground truth annotation
AI validation and performance studies with clinical-grade review
Embedded, forward-deployed pathology support for long-term program support
Use cases
Designed to support teams across the drug program lifecycle
Biomarker discovery and validation
Support early stage programs with consistent expert interpretation at scale.
Translational Research
Enable rapid insight generation to extend the bandwidth of your translational teams.
Clinical trial support
Fulfil the growing pathology interpretation demands across ongoing clinical studies.
Data preparation for downstream analysis
Deliver structured, expert reviewed outputs ready for scientific and analytical use.
The operating model
Built to fit BioPharma workflows
Scribe works seamlessly integrated in existing biopharma systems and processes, aligning with program standards and quality expectations.
Define scope and standards
Align on scientific context, interpretation criteria, and success metrics.
Embed into workflows
Operate within partner systems with minimal friction.
Deliver expert interpretation at scale
Licensed and board-certified experts support sustained volume with consistent outputs.
Quality review and iteration
Close collaboration ensures alignment and trusted results.
Why Scribe
Scale expertise seamlessly
Scribe delivers measurable improvements in consistency, capacity, and responsiveness, enabling BioPharma teams to advance drug programs while maintaining scientific integrity.
Reduce review bottlenecks while maintaining quality and accuracy.
Deploy 5-10 Scribe physicians per study, delivering statistical power and inter-reader reliability that programs demand.
Support time-sensitive programs across regions without overburdening internal teams.
Scale expert interpretation up or down across studies and phases, as program needs change.